Japan Plans Research Zones For Cutting-Edge Medicine R&D
This article was originally published in PharmAsia News
Japan's government plans to establish research zones around the nation to bring top scientists together on medical research and development efforts. The main focus of the effort, scheduled for completion later this year, is work on stem cells and other cutting-edge medicines. Subsidies and more-relaxed regulations are to be available within each zone that combines university and private industry in advanced medical research. Priority is to be given to biotech pharmaceuticals, induced pluripotent stem cells and regenerative medicine. (Click here for more - a subscription may be required
You may also be interested in...
Investors in surgical robotics company Auris say Johnson & Johnson failed to support the company per their merger agreement.
based firm, which markets Activa hand sanitizers, is offering Self+ immunity supplements in Brain, Energy and Unwind formulations in powder format for mixing with water.